Masimo Corporation (MASI) : Hussman Strategic Advisors reduced its stake in Masimo Corporation by 17.54% during the most recent quarter end. The investment management company now holds a total of 268,000 shares of Masimo Corporation which is valued at $14,252,240 after selling 57,000 shares in Masimo Corporation , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Masimo Corporation makes up approximately 2.10% of Hussman Strategic Advisors’s portfolio.
Other Hedge Funds, Including , California State Teachers Retirement System reduced its stake in MASI by selling 7,068 shares or 7.61% in the most recent quarter. The Hedge Fund company now holds 85,800 shares of MASI which is valued at $4,562,844. Masimo Corporation makes up approx 0.01% of California State Teachers Retirement System’s portfolio.Alps Advisors Inc reduced its stake in MASI by selling 752 shares or 6.87% in the most recent quarter. The Hedge Fund company now holds 10,195 shares of MASI which is valued at $532,485.Creative Planning reduced its stake in MASI by selling 80 shares or 90.91% in the most recent quarter. The Hedge Fund company now holds 8 shares of MASI which is valued at $421.Curian Capital reduced its stake in MASI by selling 16,575 shares or 73.87% in the most recent quarter. The Hedge Fund company now holds 5,862 shares of MASI which is valued at $306,758. Masimo Corporation makes up approx 0.02% of Curian Capital’s portfolio.Bnp Paribas Arbitrage Sa boosted its stake in MASI in the latest quarter, The investment management firm added 7,086 additional shares and now holds a total of 14,586 shares of Masimo Corporation which is valued at $763,285.
Masimo Corporation opened for trading at $55 and hit $59.18 on the upside on Thursday, eventually ending the session at $57.43, with a gain of 7.99% or 4.25 points. The heightened volatility saw the trading volume jump to 12,46,180 shares. Company has a market cap of $2,813 M.
On the company’s financial health, Masimo Corporation reported $0.57 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.41. The company had revenue of $172.64 million for the quarter, compared to analysts expectations of $166.03 million. The company’s revenue was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 EPS.
Many Wall Street Analysts have commented on Masimo Corporation. Company shares were Reiterated by Wedbush on Aug 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 63 from a previous price target of $60 .Masimo Corporation was Upgraded by Piper Jaffray to ” Overweight” on May 5, 2016. Company shares were Reiterated by Wedbush on May 5, 2016 to “Outperform”, Firm has raised the Price Target to $ 57 from a previous price target of $51 .
Masimo Corporation is a global medical technology company that develops manufactures and markets non-invasive patient monitoring products. The Company’s core business is measure-through-motion and low-perfusion pulse oximetry monitoring known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive optical blood constituent monitoring optical organ oximetry monitoring electrical brain function monitoring acoustic respiration monitoring and optical gas monitoring. In addition the Company offers Root patient monitoring and connectivity platform the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The Company also has the Patient SafetyNet remote patient surveillance monitoring system which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones.